Appraisal plan
Clinical evaluation template
Appraisal Plan template for medical device clinical evaluation
Use this editable Appraisal Plan to define how clinical evidence will be ranked, assessed and weighted before it feeds your Clinical Evaluation Report, PMCF activities, PMS review or safety and performance conclusions.
- Best for: clinical evaluation planning, literature appraisal, PMCF evidence review and CER preparation.
- Includes: MDCG 2020-6 ranking, D/A/P/R suitability grading, T/O/F/S/C contribution grading and Oxford Level of Evidence classification.
- Format: editable template available through the standard WooCommerce download flow.
At Lexqara, we connect clinical documentation, PMS activities and regulatory strategy so manufacturers can justify clinical evidence decisions with a clear and repeatable appraisal method. Explore the Resource Center, review our Clinical Evaluation Services, or consult MDCG 2020-6 for the clinical evidence hierarchy referenced in this template.
Template preview
Template preview: appraisal method and evidence-ranking tables
Review the key sections included in the Appraisal Plan template before downloading it. The preview shows how the document structures clinical evidence ranking, suitability assessment, contribution assessment and Oxford Level of Evidence classification for medical device clinical evaluation.
Open the HTML preview
Ranking from MDCG 2020-6 (April 2020)
Table 1: MDCG 2020-6 rank
|
Rank |
Types of clinical data and evidence |
|---|---|
|
1 |
Results of high-quality clinical investigations covering all device variants, indications, patient populations, duration of treatment effect, etc |
|
2 |
Results of high-quality clinical investigations with some gaps |
|
3 |
Outcomes from high-quality clinical data collection systems such as registries |
|
4 |
Outcomes from studies with potential methodological flaws but where data can still be quantified, and acceptability justified |
|
5 |
Equivalence data (reliable / quantifiable) |
|
6 |
Evaluation of state of the art, including evaluation of clinical data from similar devices |
|
7 |
Complaints and vigilance data; curated data |
|
8 |
Proactive PMS data, such as that derived from surveys |
|
9 |
Individual case reports on the subject device |
|
10 |
Compliance to non-clinical elements of common specifications considered relevant to device safety and performance |
|
11 |
Simulated use / animal / cadaveric testing involving healthcare professionals or other end users |
|
12 |
Pre-clinical and bench testing / compliance to standards |
Suitability
Table 2: Criteria of suitability[1]
|
Suitability criteria |
Description |
Grading System |
|
|---|---|---|---|
|
Appropriate device |
Were the data generated from the device in question? |
D1 |
Subject device |
|
D2 |
Equivalent device / similar devices |
||
|
D3 |
Similar device / alternative treatments |
||
|
Appropriate device application |
Was the device used for the same intended use (e.g., methods of deployment, application, etc.)? |
A1 |
Same use |
|
A2 |
Off-label use |
||
|
A3 |
Unspecified use |
||
|
Appropriate patient group |
Were the data generated from a patient group that is representative of the intended treatment population (e.g., age, sex, etc.) and clinical condition (i.e., disease, including state and severity)? |
P1 |
Targeted population |
|
P2 |
Contraindicated population |
||
|
P3 |
Other population |
||
|
Acceptable report/data collation |
Do the reports or collations of data contain sufficient information to be able to undertake a rational and objective assessment? |
R1 |
Key safety and performance measures |
|
R2 |
Other safety and performance measures |
||
|
R3 |
No safety and performance measure |
||
Contribution
Table 3: Criteria of contribution[2]
|
Data contribution criteria |
Description |
Grading System |
|
|---|---|---|---|
|
Data source type |
Was the design of the study appropriate? |
T1 |
Yes |
|
T2 |
No |
||
|
Outcome measures |
Do the outcome measures reported reflect the intended performance of the medical device? |
O1 |
Yes |
|
O2 |
No |
||
|
Follow up |
Is the duration of follow-up long enough to assess whether duration of treatment effects and identify complications? |
F1 |
Yes |
|
F2 |
No |
||
|
Statistical significance |
Has a statistical analysis of the data been provided and is it appropriate? |
S1 |
Yes |
|
S2 |
No |
||
|
Clinical significance |
Was the magnitude of the treatment effect observed clinically significant? |
C1 |
Yes |
|
C2 |
No |
||
Oxford Level of evidence (LoE)
Table 4: Level of clinical evidence[3] for therapy or prevention of disease
|
LoE |
Description |
|---|---|
|
1 |
Systematic reviews of randomized controlled trials Individual randomized controlled trials |
|
2 |
Systematic reviews of cohort studies Individual cohort study low quality randomized controlled trials |
|
3 |
Systematic review of case-control studies individual case-control study |
|
4 |
Case series |
|
5 |
Expert opinion |
The full editable template is available after adding the product to cart.
Related Clinical Evaluation templates
Strengthen your clinical evaluation documentation with related templates from the same Clinical Evaluation process.
- Clinical evaluation report
- Summary of Safety and Clinical Performance (SSCP)
- SSCP Readability Validation Report
- Search report for vigilance / recall
- Declaration of Interest
Need expert support? Explore Clinical Evaluation Services for Medical Devices – LEXQARA.
Free